Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Rowe

Showing results (21-30 of 269) with videos related to

Pageof 27
Sort By:
Chest|October 2, 2013
Understanding the relationship between sweat chloride and lung function in cystic fibrosisSonya L Heltshe, Nicole Mayer-Hamblett, Steven M Rowe
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 4, 2018
Colocolonic intussusception in an adult cystic fibrosis patientAdegboyega Timothy Adewale, Steven M Rowe, George M Solomon
Pediatric Pulmonology|March 1, 2018
Sensitivity of ivacaftor to drug-drug interactions with rifampin, a cytochrome P450 3A4 inducerJennifer S Guimbellot, Edward P Acosta, Steven M Rowe
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 8, 2013
Evaluating the predictive ability of sweat chlorideSonya L Heltshe, Steven M Rowe, Nicole Mayer-Hamblett
American Journal of Respiratory and Critical Care Medicine|December 21, 2019
Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical ImplicationsMarcus A Mall, Nicole Mayer-Hamblett, Steven M Rowe
Scientific American|August 11, 2011
A breath of fresh airSteven M Rowe, J P Clancy, Eric J Sorscher
The Open Respiratory Medicine Journal|May 8, 2010
Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway InflammationAmit Gaggar, Steven M Rowe, Hardision Matthew, et al.
Current Opinion in Pharmacology|November 14, 2017
The therapeutic potential of CFTR modulators for COPD and other airway diseasesGeorge M Solomon, Lianwu Fu, Steven M Rowe, et al.
Current Opinion in Pharmacology|October 21, 2018
The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosisRen-Jay Shei, Jacelyn E Peabody, Niroop Kaza, et al.
American Journal of Rhinology & Allergy|October 15, 2013
Cystic fibrosis chronic rhinosinusitis: a comprehensive reviewMohamad R Chaaban, Alexandra Kejner, Steven M Rowe, et al.
Pageof 27

Showing results (21-30 of 269) with videos related to

Sort By:
Pageof 27
Chest|October 2, 2013
Understanding the relationship between sweat chloride and lung function in cystic fibrosisSonya L Heltshe, Nicole Mayer-Hamblett, Steven M Rowe
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 4, 2018
Colocolonic intussusception in an adult cystic fibrosis patientAdegboyega Timothy Adewale, Steven M Rowe, George M Solomon
Pediatric Pulmonology|March 1, 2018
Sensitivity of ivacaftor to drug-drug interactions with rifampin, a cytochrome P450 3A4 inducerJennifer S Guimbellot, Edward P Acosta, Steven M Rowe
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|August 8, 2013
Evaluating the predictive ability of sweat chlorideSonya L Heltshe, Steven M Rowe, Nicole Mayer-Hamblett
American Journal of Respiratory and Critical Care Medicine|December 21, 2019
Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical ImplicationsMarcus A Mall, Nicole Mayer-Hamblett, Steven M Rowe
Scientific American|August 11, 2011
A breath of fresh airSteven M Rowe, J P Clancy, Eric J Sorscher
The Open Respiratory Medicine Journal|May 8, 2010
Proline-Glycine-Proline (PGP) and High Mobility Group Box Protein-1 (HMGB1): Potential Mediators of Cystic Fibrosis Airway InflammationAmit Gaggar, Steven M Rowe, Hardision Matthew, et al.
Current Opinion in Pharmacology|November 14, 2017
The therapeutic potential of CFTR modulators for COPD and other airway diseasesGeorge M Solomon, Lianwu Fu, Steven M Rowe, et al.
Current Opinion in Pharmacology|October 21, 2018
The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosisRen-Jay Shei, Jacelyn E Peabody, Niroop Kaza, et al.
American Journal of Rhinology & Allergy|October 15, 2013
Cystic fibrosis chronic rhinosinusitis: a comprehensive reviewMohamad R Chaaban, Alexandra Kejner, Steven M Rowe, et al.
Pageof 27